BIOXCEL THERAPEUTICS INC's ticker is BTAI and the CUSIP is 09075P105. A total of 109 filers reported holding BIOXCEL THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 1.62 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $781,966 | -27.8% | 41,906 | -16.9% | 0.02% | -36.0% |
| Q4 2022 | $1,083,666 | -51.9% | 50,450 | -53.2% | 0.02% | -51.9% |
| Q1 2022 | $2,252,000 | +977.5% | 107,700 | +1398.7% | 0.05% | +642.9% |
| Q2 2021 | $209,000 | -88.0% | 7,186 | -78.1% | 0.01% | -94.1% |
| Q2 2020 | $1,742,000 | -8.5% | 32,865 | -61.4% | 0.12% | -24.7% |
| Q1 2020 | $1,903,000 | +395.6% | 85,154 | +224.3% | 0.16% | +378.8% |
| Q4 2019 | $384,000 | – | 26,255 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| APIS CAPITAL ADVISORS, LLC | 40,000 | $836,000 | 1.01% |
| ACT CAPITAL MANAGEMENT, LLC | 20,000 | $418,000 | 0.44% |
| Knoll Capital Management, LLC | 20,000 | $418,000 | 0.26% |
| Artemis Investment Management LLP | 1,428,228 | $29,855,000 | 0.24% |
| Rubric Capital Management LP | 268,528 | $5,615,000 | 0.20% |
| Virtus ETF Advisers LLC | 7,713 | $161,000 | 0.07% |
| BOOTHBAY FUND MANAGEMENT, LLC | 107,700 | $2,252,000 | 0.05% |
| PDT Partners, LLC | 28,031 | $586,000 | 0.05% |
| AllSquare Wealth Management LLC | 3,162 | $66,000 | 0.04% |
| Hennion & Walsh Asset Management, Inc. | 35,221 | $736,000 | 0.04% |